The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Janux Therapeutics Inc shares valued at $178,084 were purchased by Lichter Jay on Sep 13 ’24. At $46.68 per share, Lichter Jay acquired 3,815 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Avalon BioVentures I, LP purchased 30,613 shares, netting a total of over 1,438,811 in proceeds.
Before that, Avalon BioVentures SPV I, L.P. had added 161,356 shares to its account. In a trade valued at $7,583,732, the 10% Owner bought Janux Therapeutics Inc shares for $47.00 each.
As published in their initiating research note from Stifel on September 06, 2024, Janux Therapeutics Inc [JANX] has been a Buy and the price target has been revised to $70. Analysts at Scotiabank started covering the stock with ‘”a Sector perform”‘ outlook in a report released in late May. As of March 21, 2024, BTIG Research has initiated its “Buy” rating for JANX. Earlier on March 20, 2024, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for JANX stock.
Analyzing JANX Stock Performance
During the last five days, there has been a surge of approximately 10.55%. Over the course of the year, Janux Therapeutics Inc shares have jumped approximately 350.33%. Shares of the company reached a 52-week high of $65.60 on 05/03/24 and a 52-week low of $7.79 on 02/05/24. A 50-day SMA is recorded $43.17, while a 200-day SMA reached $34.43. Nevertheless, trading volume fell to 0.51 million shares from 0.46 million shares the previous day.
Support And Resistance Levels for Janux Therapeutics Inc (JANX)
According to the 24-hour chart, there is a support level at 47.27, which, if violated, would cause prices to drop to 46.23. In the upper region, resistance lies at 50.31. The next price resistance is at 52.31. RSI (Relative Strength Index) is 58.87 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.41, which suggests the price will increase in the coming days. Percent R is at 31.83%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
